• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance.对接受主动监测的老年患者小肾肿块生长率的评估。
Eur Urol Open Sci. 2023 Mar 1;50:78-84. doi: 10.1016/j.euros.2023.02.004. eCollection 2023 Apr.
2
Five-year analysis of a multi-institutional prospective clinical trial of delayed intervention and surveillance for small renal masses: the DISSRM registry.多机构前瞻性临床试验对小肾肿瘤延迟干预和监测的 5 年分析:DISSRM 登记处。
Eur Urol. 2015 Sep;68(3):408-15. doi: 10.1016/j.eururo.2015.02.001. Epub 2015 Feb 16.
3
Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes.主动监测局限性肾肿瘤:肿瘤生长、延迟干预率和 >5 年临床结局。
Eur Urol. 2018 Aug;74(2):157-164. doi: 10.1016/j.eururo.2018.03.011. Epub 2018 Apr 4.
4
Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.小肾肿物监测:活检特征队列中的组织学特异性生长率
Eur Urol. 2020 Sep;78(3):460-467. doi: 10.1016/j.eururo.2020.06.053. Epub 2020 Jul 14.
5
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.小肾肿瘤的主动监测:早期肾癌的进展模式。
Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1.
6
Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.主动监测中小肾肿瘤生长动力学:DISSRM 登记处的变异性和结果。
J Urol. 2018 Mar;199(3):641-648. doi: 10.1016/j.juro.2017.09.087. Epub 2017 Sep 23.
7
The role of active surveillance of small renal masses.小肾肿瘤主动监测的作用。
Int J Surg. 2016 Dec;36(Pt C):518-524. doi: 10.1016/j.ijsu.2016.06.007. Epub 2016 Jun 15.
8
Active surveillance of small renal masses.小肾肿块的主动监测
Insights Imaging. 2020 May 5;11(1):63. doi: 10.1186/s13244-020-00853-y.
9
Association of Clear Cell Likelihood Score on MRI and Growth Kinetics of Small Solid Renal Masses on Active Surveillance.磁共振成像上透明细胞可能性评分与主动监测中小肾脏实性肿块生长动力学的关系。
AJR Am J Roentgenol. 2022 Jan;218(1):101-110. doi: 10.2214/AJR.21.25979. Epub 2021 Jul 21.
10
Active Surveillance for Small Renal Masses: When Less is More.小肾肿瘤的主动监测:少即是多。
Eur Urol Focus. 2016 Dec 15;2(6):660-668. doi: 10.1016/j.euf.2017.04.004. Epub 2017 Apr 19.

引用本文的文献

1
Durability of Active Surveillance for Localized Renal Masses: 3-year Outcomes in the Michigan Urological Surgery Improvement Collaborative.局限性肾肿块主动监测的耐久性:密歇根泌尿外科手术改进协作组的3年结果
Eur Urol Open Sci. 2025 Mar 26;75:11-19. doi: 10.1016/j.euros.2025.02.005. eCollection 2025 May.
2
Pathological and Inflammatory Consequences of Aging.衰老的病理和炎症后果
Biomolecules. 2025 Mar 12;15(3):404. doi: 10.3390/biom15030404.
3
The evolving management of small renal masses.小肾肿瘤的不断演变的治疗策略。
Nat Rev Urol. 2024 Jul;21(7):406-421. doi: 10.1038/s41585-023-00848-6. Epub 2024 Feb 16.

本文引用的文献

1
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南:2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.
2
Renal Mass and Localized Renal Cancer: Evaluation, Management, and Follow-up: AUA Guideline: Part II.肾肿物与局限性肾癌:评估、管理及随访:美国泌尿外科学会指南:第二部分
J Urol. 2021 Aug;206(2):209-218. doi: 10.1097/JU.0000000000001912. Epub 2021 Jul 11.
3
Outcomes of Active Surveillance for Young Patients with Small Renal Masses: Prospective Data from the DISSRM Registry.主动监测对小肾肿块年轻患者的结果:DISSRM 登记处的前瞻性数据。
J Urol. 2021 May;205(5):1286-1293. doi: 10.1097/JU.0000000000001575. Epub 2020 Dec 24.
4
Active surveillance for small renal masses in elderly patients does not increase overall mortality rates compared to primary intervention: a propensity score weighted analysis.与初次干预相比,对老年患者小肾脏肿块进行主动监测并不会增加总体死亡率:一项倾向评分加权分析。
Minerva Urol Nephrol. 2021 Dec;73(6):781-788. doi: 10.23736/S2724-6051.20.03785-6. Epub 2020 Sep 29.
5
Triggers for delayed intervention in patients with small renal masses undergoing active surveillance: a systematic review.主动监测中小肾肿瘤患者延迟干预的触发因素:系统评价。
Minerva Urol Nefrol. 2020 Aug;72(4):389-407. doi: 10.23736/S0393-2249.20.03870-9.
6
Small Renal Mass Surveillance: Histology-specific Growth Rates in a Biopsy-characterized Cohort.小肾肿物监测:活检特征队列中的组织学特异性生长率
Eur Urol. 2020 Sep;78(3):460-467. doi: 10.1016/j.eururo.2020.06.053. Epub 2020 Jul 14.
7
How the ageing microenvironment influences tumour progression.衰老微环境如何影响肿瘤进展。
Nat Rev Cancer. 2020 Feb;20(2):89-106. doi: 10.1038/s41568-019-0222-9. Epub 2019 Dec 13.
8
The incidence, predictors, and survival of disappearing small renal masses on active surveillance.主动监测中小肾肿瘤消失的发生率、预测因素和生存率。
Urol Oncol. 2020 Feb;38(2):42.e1-42.e6. doi: 10.1016/j.urolonc.2019.10.005. Epub 2019 Nov 6.
9
Role of Active Surveillance for Localized Small Renal Masses.局限性小肾癌的主动监测作用。
Eur Urol Oncol. 2018 Aug;1(3):177-187. doi: 10.1016/j.euo.2018.05.001. Epub 2018 May 26.
10
Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.小肾肿瘤患者管理方案的比较效果:一项前瞻性队列研究。
BJU Int. 2019 Jan;123(1):42-50. doi: 10.1111/bju.14490. Epub 2018 Aug 9.

对接受主动监测的老年患者小肾肿块生长率的评估。

Evaluation of Growth Rates for Small Renal Masses in Elderly Patients Undergoing Active Surveillance.

作者信息

Alam Ridwan, Yerrapragada Anirudh, Wlajnitz Tina, Watts Emelia, Pallauf Maximilian, Enikeev Dmitry, Chang Peter, Wagner Andrew A, McKiernan James M, Pierorazio Phillip M, Allaf Mohamad E, Singla Nirmish

机构信息

Department of Urology, James Buchanan Brady Urological Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

Nova Southeastern University Dr. Kiran C. Patel College of Allopathic Medicine, Fort Lauderdale, FL, USA.

出版信息

Eur Urol Open Sci. 2023 Mar 1;50:78-84. doi: 10.1016/j.euros.2023.02.004. eCollection 2023 Apr.

DOI:10.1016/j.euros.2023.02.004
PMID:37101773
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10123410/
Abstract

BACKGROUND

As the adoption of active surveillance (AS) for small renal masses (SRMs) grows, the number of elderly patients enrolled for a prolonged period of time will increase. However, our understanding of comparative growth rates (GRs) in aging patients with SRMs remains poor.

OBJECTIVE

To examine whether particular age cutoffs are associated with an increased GR for patients undergoing AS for SRMs.

DESIGN SETTING AND PARTICIPANTS

We identified all patients with SRMs enrolled in the multi-institutional, prospective Delayed Intervention and Surveillance for Small Renal Masses (DISSRM) registry since 2009 who elected for AS.

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Two definitions of GR were examined: GR from the initial image (GR) and GR from the prior image (GR). Image measurements were dichotomized based on patient age at the time of imaging. Multiple age cutoffs were examined: 65, 70, 75, and 80 yr. Mixed-effect linear regression examined the associations between age and GR, with controlling to account for multiple measurements from the same individual.

RESULTS AND LIMITATIONS

We examined 2542 measurements from 571 patients. The median age at enrollment was 70.9 yr (interquartile range [IQR] 63.2-77.4) with a median tumor diameter of 1.8 cm (IQR 1.4-2.5). As a continuous variable, age was not associated with GR (-0.0001 cm/yr, 95% confidence interval [CI] -0.007 to 0.007,  = 0.97) or GR (0.008 cm/yr, 95% CI -0.004 to 0.020,  = 0.17) after adjustment. The only age thresholds associated with an increased GR were 65 yr for GR and 70 yr for GR. Limitations include the one-dimensional nature of the measurements used.

CONCLUSIONS

Increased age for patients on AS for SRMs is not associated with increased GRs.

PATIENT SUMMARY

We examined whether patients undergoing active surveillance (AS) exhibited accelerated growth of their small renal masses (SRMs) after a certain age. No demonstrable change was seen, suggesting that AS is a safe and durable management option for aging patients with SRMs.

摘要

背景

随着对小肾肿块(SRM)采用主动监测(AS)的情况增多,长期参与监测的老年患者数量将会增加。然而,我们对老年SRM患者的相对生长率(GR)的了解仍然不足。

目的

探讨对于接受SRM主动监测的患者,特定的年龄界限是否与生长率增加相关。

设计、设置与参与者:我们确定了自2009年以来在多机构前瞻性小肾肿块延迟干预与监测(DISSRM)注册研究中入选并选择接受AS的所有SRM患者。

结局测量与统计分析

研究了生长率的两种定义:初始图像的生长率(GR)和前次图像的生长率(GR)。图像测量结果根据成像时患者的年龄进行二分法划分。研究了多个年龄界限:65岁、70岁、75岁和80岁。采用混合效应线性回归分析年龄与生长率之间的关联,并对来自同一患者的多次测量结果进行控制。

结果与局限性

我们分析了571例患者的2542次测量结果。入组时的中位年龄为70.9岁(四分位间距[IQR]63.2 - 77.4),肿瘤中位直径为1.8 cm(IQR 1.4 - 2.5)。作为连续变量,调整后年龄与GR(-0.0001 cm/年,95%置信区间[CI] -0.007至0.007,P = 0.97)或GR(0.008 cm/年,95% CI -0.004至0.020,P = 0.17)均无关联。与生长率增加相关的唯一年龄界限是GR为65岁,GR为70岁。局限性包括所使用测量方法的一维性质。

结论

接受SRM主动监测的患者年龄增加与生长率增加无关。

患者总结

我们研究了接受主动监测(AS)的患者在达到一定年龄后其小肾肿块(SRM)是否出现加速生长。未观察到明显变化,这表明AS对于老年SRM患者是一种安全且持久的管理选择。